UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002154 |
|---|---|
| Receipt number | R000002629 |
| Scientific Title | Randomized phase II study comparing 2nd line therapy for gemcitabine-refractry advanced pancreatic cancer. |
| Date of disclosure of the study information | 2009/07/02 |
| Last modified on | 2017/05/16 19:12:43 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/07/02 09:32:11 | ||
| 2 | Update | 2010/01/04 11:31:23 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 3 | Update | 2011/01/03 16:26:17 | Date trial data considered complete Date analysis concluded Publication of results |
|
| 4 | Update | 2011/07/02 09:31:49 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 5 | Update | 2012/07/03 09:24:40 | Recruitment status |
|
| 6 | Update | 2017/05/16 19:12:43 | TEL Name of primary person or sponsor Organization |
